CRESCENT CAPITAL BDC INC (CCAP) Fundamental Analysis & Valuation

NASDAQ:CCAPUS2256551092

Current stock price

13.22 USD
+0.02 (+0.15%)
At close:
13.22 USD
0 (0%)
After Hours:

This CCAP fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. CCAP Profitability Analysis

1.1 Basic Checks

  • In the past year CCAP was profitable.
  • In the past year CCAP had a positive cash flow from operations.
  • Each year in the past 5 years CCAP has been profitable.
  • CCAP had a positive operating cash flow in 4 of the past 5 years.
CCAP Yearly Net Income VS EBIT VS OCF VS FCFCCAP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M -100M -150M -200M

1.2 Ratios

  • CCAP's Return On Assets of 2.13% is in line compared to the rest of the industry. CCAP outperforms 46.67% of its industry peers.
  • The Return On Equity of CCAP (4.89%) is worse than 60.42% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 3.43%, CCAP is in line with its industry, outperforming 43.75% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for CCAP is below the industry average of 7.30%.
Industry RankSector Rank
ROA 2.13%
ROE 4.89%
ROIC 3.43%
ROA(3y)3.91%
ROA(5y)3.85%
ROE(3y)8.71%
ROE(5y)8.29%
ROIC(3y)4.01%
ROIC(5y)3.76%
CCAP Yearly ROA, ROE, ROICCCAP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

  • CCAP's Profit Margin of 20.63% is in line compared to the rest of the industry. CCAP outperforms 55.83% of its industry peers.
  • In the last couple of years the Profit Margin of CCAP has declined.
  • CCAP has a better Operating Margin (41.01%) than 73.75% of its industry peers.
  • CCAP's Operating Margin has declined in the last couple of years.
  • With a Gross Margin value of 43.45%, CCAP perfoms like the industry average, outperforming 47.08% of the companies in the same industry.
  • CCAP's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 41.01%
PM (TTM) 20.63%
GM 43.45%
OM growth 3Y-7.21%
OM growth 5Y-8.9%
PM growth 3Y15.81%
PM growth 5Y-21.89%
GM growth 3Y-3.66%
GM growth 5Y-8.9%
CCAP Yearly Profit, Operating, Gross MarginsCCAP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

1

2. CCAP Health Analysis

2.1 Basic Checks

  • CCAP has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for CCAP has been increased compared to 5 years ago.
  • CCAP has a worse debt/assets ratio than last year.
CCAP Yearly Shares OutstandingCCAP Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
CCAP Yearly Total Debt VS Total AssetsCCAP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • CCAP has an Altman-Z score of 0.33. This is a bad value and indicates that CCAP is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of CCAP (0.33) is worse than 71.25% of its industry peers.
  • CCAP has a debt to FCF ratio of 11.69. This is a negative value and a sign of low solvency as CCAP would need 11.69 years to pay back of all of its debts.
  • CCAP has a Debt to FCF ratio of 11.69. This is comparable to the rest of the industry: CCAP outperforms 58.75% of its industry peers.
  • A Debt/Equity ratio of 1.24 is on the high side and indicates that CCAP has dependencies on debt financing.
  • CCAP has a worse Debt to Equity ratio (1.24) than 60.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.24
Debt/FCF 11.69
Altman-Z 0.33
ROIC/WACCN/A
WACCN/A
CCAP Yearly LT Debt VS Equity VS FCFCCAP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M 600M 800M

2.3 Liquidity

  • A Current Ratio of 0.33 indicates that CCAP may have some problems paying its short term obligations.
  • CCAP has a worse Current ratio (0.33) than 81.25% of its industry peers.
  • CCAP has a Quick Ratio of 0.33. This is a bad value and indicates that CCAP is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.33, CCAP is doing worse than 81.25% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.33
Quick Ratio 0.33
CCAP Yearly Current Assets VS Current LiabilitesCCAP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

2

3. CCAP Growth Analysis

3.1 Past

  • CCAP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -28.35%.
  • Measured over the past 5 years, CCAP shows a small growth in Earnings Per Share. The EPS has been growing by 0.22% on average per year.
  • The Revenue for CCAP has decreased by -15.24% in the past year. This is quite bad
  • Measured over the past years, CCAP shows a quite strong growth in Revenue. The Revenue has been growing by 16.76% on average per year.
EPS 1Y (TTM)-28.35%
EPS 3Y1.51%
EPS 5Y0.22%
EPS Q2Q%-18.18%
Revenue 1Y (TTM)-15.24%
Revenue growth 3Y12.75%
Revenue growth 5Y16.76%
Sales Q2Q%-12.04%

3.2 Future

  • CCAP is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -4.07% yearly.
  • The Revenue is expected to decrease by -5.04% on average over the next years.
EPS Next Y-8.17%
EPS Next 2Y-6.32%
EPS Next 3Y-4.07%
EPS Next 5YN/A
Revenue Next Year-6.03%
Revenue Next 2Y-4.33%
Revenue Next 3Y-5.04%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CCAP Yearly Revenue VS EstimatesCCAP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 50M 100M 150M 200M
CCAP Yearly EPS VS EstimatesCCAP Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2 2.5

6

4. CCAP Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 7.26, which indicates a rather cheap valuation of CCAP.
  • Compared to the rest of the industry, the Price/Earnings ratio of CCAP indicates a rather cheap valuation: CCAP is cheaper than 82.08% of the companies listed in the same industry.
  • CCAP's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.42.
  • The Price/Forward Earnings ratio is 7.91, which indicates a rather cheap valuation of CCAP.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CCAP indicates a rather cheap valuation: CCAP is cheaper than 83.33% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.29, CCAP is valued rather cheaply.
Industry RankSector Rank
PE 7.26
Fwd PE 7.91
CCAP Price Earnings VS Forward Price EarningsCCAP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 80.83% of the companies in the same industry are more expensive than CCAP, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 6.54
EV/EBITDA N/A
CCAP Per share dataCCAP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • A cheap valuation may be justified as CCAP's earnings are expected to decrease with -4.07% in the coming years.
PEG (NY)N/A
PEG (5Y)32.83
EPS Next 2Y-6.32%
EPS Next 3Y-4.07%

5

5. CCAP Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 12.73%, CCAP is a good candidate for dividend investing.
  • CCAP's Dividend Yield is a higher than the industry average which is at 6.53.
  • Compared to an average S&P500 Dividend Yield of 1.81, CCAP pays a better dividend.
Industry RankSector Rank
Dividend Yield 12.73%

5.2 History

  • The dividend of CCAP has a limited annual growth rate of 1.08%.
  • CCAP has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)1.08%
Div Incr Years0
Div Non Decr Years0
CCAP Yearly Dividends per shareCCAP Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • CCAP pays out 196.51% of its income as dividend. This is not a sustainable payout ratio.
  • CCAP's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP196.51%
EPS Next 2Y-6.32%
EPS Next 3Y-4.07%
CCAP Yearly Income VS Free CF VS DividendCCAP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M -100M -150M -200M
CCAP Dividend Payout.CCAP Dividend Payout, showing the Payout Ratio.CCAP Dividend Payout.PayoutRetained Earnings

CCAP Fundamentals: All Metrics, Ratios and Statistics

CRESCENT CAPITAL BDC INC

NASDAQ:CCAP (4/24/2026, 8:25:30 PM)

After market: 13.22 0 (0%)

13.22

+0.02 (+0.15%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)02-25
Earnings (Next)05-13
Inst Owners59.21%
Inst Owner Change-0.43%
Ins Owners1.17%
Ins Owner Change0.03%
Market Cap488.74M
Revenue(TTM)167.28M
Net Income(TTM)34.51M
Analysts82.86
Price Target15.49 (17.17%)
Short Float %1.57%
Short Ratio2.34
Dividend
Industry RankSector Rank
Dividend Yield 12.73%
Yearly Dividend1.83
Dividend Growth(5Y)1.08%
DP196.51%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-31
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.49%
Min EPS beat(2)-4.13%
Max EPS beat(2)1.15%
EPS beat(4)1
Avg EPS beat(4)-5.6%
Min EPS beat(4)-15.91%
Max EPS beat(4)1.15%
EPS beat(8)3
Avg EPS beat(8)0.91%
EPS beat(12)7
Avg EPS beat(12)2.18%
EPS beat(16)9
Avg EPS beat(16)1.81%
Revenue beat(2)0
Avg Revenue beat(2)-2.08%
Min Revenue beat(2)-4%
Max Revenue beat(2)-0.16%
Revenue beat(4)0
Avg Revenue beat(4)-3.35%
Min Revenue beat(4)-8.38%
Max Revenue beat(4)-0.16%
Revenue beat(8)3
Avg Revenue beat(8)-1.44%
Revenue beat(12)6
Avg Revenue beat(12)-0.22%
Revenue beat(16)7
Avg Revenue beat(16)-0.01%
PT rev (1m)-3.35%
PT rev (3m)-3.35%
EPS NQ rev (1m)-1.08%
EPS NQ rev (3m)0.49%
EPS NY rev (1m)-1.14%
EPS NY rev (3m)1.6%
Revenue NQ rev (1m)-0.95%
Revenue NQ rev (3m)-0.6%
Revenue NY rev (1m)-0.32%
Revenue NY rev (3m)0.01%
Valuation
Industry RankSector Rank
PE 7.26
Fwd PE 7.91
P/S 2.92
P/FCF 6.54
P/OCF 6.54
P/B 0.69
P/tB 0.69
EV/EBITDA N/A
EPS(TTM)1.82
EY13.77%
EPS(NY)1.67
Fwd EY12.64%
FCF(TTM)2.02
FCFY15.29%
OCF(TTM)2.02
OCFY15.29%
SpS4.52
BVpS19.1
TBVpS19.1
PEG (NY)N/A
PEG (5Y)32.83
Graham Number27.9651 (111.54%)
Profitability
Industry RankSector Rank
ROA 2.13%
ROE 4.89%
ROCE 4.34%
ROIC 3.43%
ROICexc 3.44%
ROICexgc 3.44%
OM 41.01%
PM (TTM) 20.63%
GM 43.45%
FCFM 44.67%
ROA(3y)3.91%
ROA(5y)3.85%
ROE(3y)8.71%
ROE(5y)8.29%
ROIC(3y)4.01%
ROIC(5y)3.76%
ROICexc(3y)4.03%
ROICexc(5y)3.78%
ROICexgc(3y)4.04%
ROICexgc(5y)3.8%
ROCE(3y)5.07%
ROCE(5y)4.76%
ROICexgc growth 3Y-3.13%
ROICexgc growth 5Y-2.25%
ROICexc growth 3Y-2.88%
ROICexc growth 5Y-2.28%
OM growth 3Y-7.21%
OM growth 5Y-8.9%
PM growth 3Y15.81%
PM growth 5Y-21.89%
GM growth 3Y-3.66%
GM growth 5Y-8.9%
F-Score5
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 1.24
Debt/FCF 11.69
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.32
Cash Conversion N/A
Profit Quality 216.53%
Current Ratio 0.33
Quick Ratio 0.33
Altman-Z 0.33
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)135.54%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-28.35%
EPS 3Y1.51%
EPS 5Y0.22%
EPS Q2Q%-18.18%
EPS Next Y-8.17%
EPS Next 2Y-6.32%
EPS Next 3Y-4.07%
EPS Next 5YN/A
Revenue 1Y (TTM)-15.24%
Revenue growth 3Y12.75%
Revenue growth 5Y16.76%
Sales Q2Q%-12.04%
Revenue Next Year-6.03%
Revenue Next 2Y-4.33%
Revenue Next 3Y-5.04%
Revenue Next 5YN/A
EBIT growth 1Y-24.27%
EBIT growth 3Y4.62%
EBIT growth 5Y6.36%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y26.85%
FCF growth 3Y38.79%
FCF growth 5YN/A
OCF growth 1Y26.85%
OCF growth 3Y38.79%
OCF growth 5YN/A

CRESCENT CAPITAL BDC INC / CCAP Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CRESCENT CAPITAL BDC INC (CCAP) stock?

ChartMill assigns a fundamental rating of 3 / 10 to CCAP.


What is the valuation status for CCAP stock?

ChartMill assigns a valuation rating of 6 / 10 to CRESCENT CAPITAL BDC INC (CCAP). This can be considered as Fairly Valued.


How profitable is CRESCENT CAPITAL BDC INC (CCAP) stock?

CRESCENT CAPITAL BDC INC (CCAP) has a profitability rating of 3 / 10.


How financially healthy is CRESCENT CAPITAL BDC INC?

The financial health rating of CRESCENT CAPITAL BDC INC (CCAP) is 1 / 10.


Can you provide the expected EPS growth for CCAP stock?

The Earnings per Share (EPS) of CRESCENT CAPITAL BDC INC (CCAP) is expected to decline by -8.17% in the next year.